Logo

IntegraGen and Aventis Ink Schizophrenia Research Collaboration

Jan 30, 2004

NEW YORK, Jan. 30 (GenomeWeb News) - IntegraGen and Aventis will jointly search for genes associated with schizophrenia, the companies said today.

 

Aventis will use IntegraGen's Genome Hybrid Identity Profiling gene mapping technology to perform genome-wide linkage analysis on DNA samples from schizophrenia patients, collected by Aventis' Human Genetics Center in Evry, France.

 

This is IntegraGen's first commercial deal for the application of GenomeHIP, according to the company, which is located in suburban Paris.

 

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.